Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119797748> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2119797748 endingPage "355" @default.
- W2119797748 startingPage "348" @default.
- W2119797748 abstract "Recombinant human erythropoietin (rHuEPO) improves chronic anemia of cancer, but the proportion of patients who respond favorably to the treatment varies depending on the type of neoplasia. Preliminary data of the two malignancies with the highest response rates, namely, multiple myeloma and squamous cell carcinoma, are reported. Twenty patients with multiple myeloma and 14 with squamous cell carcinoma, who had presented with hemoglobin levels <11 g/dl, were treated with rHuEPO, 150 U/kg, three times/week. Response, defined as an increase of at least 2 g/dl hemoglobin within 12 weeks, was achieved by 15 myeloma patients (75%) and 11 patients with squamous cell carcinoma (79%). Tolerance of the treatment was excellent. The WHO performance status and quality of life improved in responders. The remarkably low levels of endogenous EPO in our patients with squamous cell carcinoma, most of whom had been treated with cisplatin-or carbo-platin-containing regimens, suggest that anemia in these cases had been at least partly chemotherapy induced. In myeloma patients, the blunted EPO response to the anemic condition may have been partly caused by subclinical tubular insufficiency induced by toxic paraproteins. Future studies should aim to elucidate factors which are responsible for the inability of some patients to respond to rHuEPO treatment, even though in multiple myeloma and squamous cell carcinoma these non-responders are a small minority." @default.
- W2119797748 created "2016-06-24" @default.
- W2119797748 creator A5028662013 @default.
- W2119797748 creator A5046839590 @default.
- W2119797748 creator A5054972332 @default.
- W2119797748 creator A5057395053 @default.
- W2119797748 date "1993-01-01" @default.
- W2119797748 modified "2023-09-24" @default.
- W2119797748 title "Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma" @default.
- W2119797748 cites W1575336769 @default.
- W2119797748 cites W1822925937 @default.
- W2119797748 cites W1983166974 @default.
- W2119797748 cites W1997526422 @default.
- W2119797748 cites W2013072910 @default.
- W2119797748 cites W2016864596 @default.
- W2119797748 cites W2017775669 @default.
- W2119797748 cites W2022322178 @default.
- W2119797748 cites W2050280961 @default.
- W2119797748 cites W2077147171 @default.
- W2119797748 cites W2083758851 @default.
- W2119797748 cites W2089632980 @default.
- W2119797748 cites W2268186367 @default.
- W2119797748 cites W2329804409 @default.
- W2119797748 cites W2340124568 @default.
- W2119797748 cites W2397025146 @default.
- W2119797748 doi "https://doi.org/10.1002/stem.5530110502" @default.
- W2119797748 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8241947" @default.
- W2119797748 hasPublicationYear "1993" @default.
- W2119797748 type Work @default.
- W2119797748 sameAs 2119797748 @default.
- W2119797748 citedByCount "31" @default.
- W2119797748 crossrefType "journal-article" @default.
- W2119797748 hasAuthorship W2119797748A5028662013 @default.
- W2119797748 hasAuthorship W2119797748A5046839590 @default.
- W2119797748 hasAuthorship W2119797748A5054972332 @default.
- W2119797748 hasAuthorship W2119797748A5057395053 @default.
- W2119797748 hasConcept C121608353 @default.
- W2119797748 hasConcept C126322002 @default.
- W2119797748 hasConcept C143998085 @default.
- W2119797748 hasConcept C203014093 @default.
- W2119797748 hasConcept C2776364478 @default.
- W2119797748 hasConcept C2776694085 @default.
- W2119797748 hasConcept C2777546739 @default.
- W2119797748 hasConcept C2778248108 @default.
- W2119797748 hasConcept C2778534260 @default.
- W2119797748 hasConcept C2778917026 @default.
- W2119797748 hasConcept C71924100 @default.
- W2119797748 hasConcept C90924648 @default.
- W2119797748 hasConceptScore W2119797748C121608353 @default.
- W2119797748 hasConceptScore W2119797748C126322002 @default.
- W2119797748 hasConceptScore W2119797748C143998085 @default.
- W2119797748 hasConceptScore W2119797748C203014093 @default.
- W2119797748 hasConceptScore W2119797748C2776364478 @default.
- W2119797748 hasConceptScore W2119797748C2776694085 @default.
- W2119797748 hasConceptScore W2119797748C2777546739 @default.
- W2119797748 hasConceptScore W2119797748C2778248108 @default.
- W2119797748 hasConceptScore W2119797748C2778534260 @default.
- W2119797748 hasConceptScore W2119797748C2778917026 @default.
- W2119797748 hasConceptScore W2119797748C71924100 @default.
- W2119797748 hasConceptScore W2119797748C90924648 @default.
- W2119797748 hasIssue "5" @default.
- W2119797748 hasLocation W21197977481 @default.
- W2119797748 hasLocation W21197977482 @default.
- W2119797748 hasOpenAccess W2119797748 @default.
- W2119797748 hasPrimaryLocation W21197977481 @default.
- W2119797748 hasRelatedWork W102865230 @default.
- W2119797748 hasRelatedWork W1541239202 @default.
- W2119797748 hasRelatedWork W1996821186 @default.
- W2119797748 hasRelatedWork W2036885415 @default.
- W2119797748 hasRelatedWork W2060861099 @default.
- W2119797748 hasRelatedWork W2349219311 @default.
- W2119797748 hasRelatedWork W2375327560 @default.
- W2119797748 hasRelatedWork W2390387684 @default.
- W2119797748 hasRelatedWork W2408491776 @default.
- W2119797748 hasRelatedWork W2427676689 @default.
- W2119797748 hasVolume "11" @default.
- W2119797748 isParatext "false" @default.
- W2119797748 isRetracted "false" @default.
- W2119797748 magId "2119797748" @default.
- W2119797748 workType "article" @default.